Cargando…
Osteoporosis in a 60-Year-Old Male With a History of Chronic Myeloid Leukemia Treated With Imatinib Mesylate
Secondary osteoporosis is defined as a decline in bone mineral density due to any underlying etiology, which usually results in accelerated bone loss than expected for the individual’s age or gender. Almost 50-80% of men diagnosed with osteoporosis have secondary osteoporosis. We present a case of a...
Autores principales: | Batra, Jaskaran, Ankireddypalli, Anvitha R, Kanugula, Ashok Kumar, Gorle, Swathi, Kaur, Jasleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263172/ https://www.ncbi.nlm.nih.gov/pubmed/37325683 http://dx.doi.org/10.7759/cureus.40368 |
Ejemplares similares
-
Thyrotoxic Periodic Paralysis With Severe Hypokalemia Precipitated by Acute Alcohol Intoxication in a Patient With Graves’ Disease
por: Batra, Jaskaran, et al.
Publicado: (2023) -
Guillain-Barre Syndrome Secondary to the Use of Dabrafenib and Trametinib for the Treatment of Advanced Thyroid Carcinoma
por: Batra, Jaskaran, et al.
Publicado: (2023) -
Progesterone Hypersensitivity Induced by Exogenous Progesterone Exposure
por: Dhaliwal, Gurnoor, et al.
Publicado: (2023) -
Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States
por: Kanugula, Ashok Kumar, et al.
Publicado: (2023) -
Acute Iridocyclitis Associated With Intravenous Zoledronic Acid: A Case Report
por: Ankireddypalli, Anvitha R, et al.
Publicado: (2023)